http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005080283-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-412
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C55-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-02
filingDate 2003-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f252080ce513df74d238975972465d56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_954785fc0b9dff64070e2ecee643a795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad66d88944298fc850f0104d5cef87fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e47f2f57d8f0adbe58f7ae3d5cab4e2
publicationDate 2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2005080283-A1
titleOfInvention Pharmaceutical-grade ferric citrate
abstract The present invention relates to pharmaceutical-grade ferric citrate. Pharmaceutical-grade ferric citrate contains a definite composition and a definite hydrate. The present invention also relates to a method using a solid-solid reaction to produce pharmaceutical-grade ferric citrate. The present invention also relates to a pharmaceutical composition comprising a therapeutically effective amount of pharmaceutical-grade ferric citrate and a food comprising pharmaceutical-grade ferric citrate.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018009027-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9624155-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9050316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012162522-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9913821-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846976-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016145232-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016162794-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009504777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609896-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9328133-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5944077-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009186939-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757416-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8754258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015110968-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8754257-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8901349-B2
priorityDate 2003-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5753706-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13020083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22230

Total number of triples: 40.